Sorry, you need to enable JavaScript to visit this website.

Did you know? Updated COVID-19 boosters designed for recent Omicron variants are available for eligible people. Check eligibility and schedule an appointment on the CDC site today.

Skip to main content

Top Menu

  • Indication Indication

    VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.

  • Important Safety Information
  • Patient Information
  • Full Prescribing Information
  • For Healthcare Professionals

Main Menu

  • Home
  • About ATTR-CM
    • What is ATTR-CM?
    • The impact of ATTR-CM
    • Taking action
  • Why VYNDAMAX?
    • How VYNDAMAX may help
    • How VYNDAMAX works
    • Talking to your doctor
  • Taking VYNDAMAX
    • VYNDAMAX dosing & side effects
    • Starting on VYNDAMAX
    • Staying on VYNDAMAX
  • Support and Resources
    • Financial assistance
    • Hereditary ATTR-CM resources
    • Caregiver support
    • Downloadable brochures
    • Advocacy groups
  • Sign Up
  • Indication
  • Important Safety Information
  • Patient Information
  • Full Prescribing Information
  • For Healthcare Professionals

More time for your heart. Live longer. It’s possible.

VYNDAMAX® (tafamidis) is the first and only, once-daily, single-capsule treatment for both the wild-type and hereditary forms of transthyretin amyloid cardiomyopathy (ATTR-CM), a rare and serious condition.

See if VYNDAMAX is right for you Looking for information on VYNDAQEL
VYNDAMAX® (tafamidis) is the first and only single-capsule treatment for both wild-type & hereditary ATTR-CM. See Safety Info
VYNDAMAX® (tafamidis) is the first and only single-capsule treatment for both wild-type & hereditary ATTR-CM. See Safety Info

More time for your heart. Live longer. It’s possible.

VYNDAMAX® (tafamidis) is the first and only, once-daily, single-capsule treatment for both the wild-type and hereditary forms of transthyretin amyloid cardiomyopathy (ATTR-CM), a rare and serious condition.

See if VYNDAMAX is right for you Looking for information on VYNDAQEL
Recently diagnosed with ATTR-CM?
Considering taking VYNDAMAX?
Already taking VYNDAMAX?

Stan’s VYNDAMAX journey

Stan's experience with VYNDAMAX (tafamidis)

Stan’s VYNDAMAX journey

Hear from Stan, a real patient currently taking VYNDAMAX. Explore the site to find videos and quotes from Stan as he discusses his diagnosis journey, experience on treatment, and more. 

VyndaCares

Get to the heart of what to know about ATTR-CM and VYNDAMAX

Sign up to receive educational materials and emails throughout your treatment journey.

Sign up today

IMPORTANT SAFETY INFORMATION AND INDICATION

View More
Before taking VYNDAMAX, tell your healthcare provider about all your medical conditions, including if you:
  • have liver problems.
  • are pregnant or plan to become pregnant.
  • are breastfeeding or plan to breastfeed.
Tell your healthcare provider about all the medicines you take including any prescription or over‑the‑counter medicines, vitamins, and herbal supplements.
There were no known side effects that happened during treatment with VYNDAMAX.
Indication
VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.
 

IMPORTANT SAFETY INFORMATION AND INDICATION

Before taking VYNDAMAX, tell your healthcare provider about all your medical conditions, including if you:
  • have liver problems.
  • are pregnant or plan to become pregnant.
  • are breastfeeding or plan to breastfeed.
Tell your healthcare provider about all the medicines you take including any prescription or over‑the‑counter medicines, vitamins, and herbal supplements.
There were no known side effects that happened during treatment with VYNDAMAX.
Indication
VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.
 
logo
Report Adverse Events Terms of Use Privacy Policy Contact Us About Pfizer Site Map
Patients should always ask their doctors for medical advice about adverse events.
You are encouraged to report adverse events related to Pfizer products by calling 1-800-438-1985 (U.S. only). If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. Visit www.fda.gov/MedWatch or call 1-800-FDA-1088.
This site is intended only for U.S. residents. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only and is not intended to replace discussions with a healthcare provider.
© 2022 Pfizer Inc. All rights reserved.
August 2022 PP-VDM-USA-0967

IMPORTANT SAFETY INFORMATION AND INDICATION

View More
Before taking VYNDAMAX, tell your healthcare provider about all your medical conditions, including if you:
  • have liver problems.
  • are pregnant or plan to become pregnant.
  • are breastfeeding or plan to breastfeed.
Tell your healthcare provider about all the medicines you take including any prescription or over‑the‑counter medicines, vitamins, and herbal supplements.
There were no known side effects that happened during treatment with VYNDAMAX.
Indication
VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.

You are now leaving VYNDAMAX.com.

Links to other websites are provided as a convenience to the viewer. Pfizer accepts no responsibility for the content of linked sites.

You are now leaving VYNDAMAX.com.

The information provided in this website is intended only for healthcare professionals in the United States.

Indication

VYNDAMAX is a prescription medicine used to treat adults with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce death and hospitalization related to heart problems. It is not known if VYNDAMAX is safe and effective in children.